{"product_id":"pulmonary-embolism-isbn-9781119039082","title":"Pulmonary Embolism","description":"A must have resource for clinicians and investigators  interested in pulmonary embolism and deep venous thrombosis\u003cbr\u003e \u003cul\u003e \u003cli\u003eHighly illustrated with numerous tables and graphs alongside clear concise text\u003c\/li\u003e \u003cli\u003eIncludes chapters addressing pulmonary embolism (PE) and deep venous thrombosis (DVT) in relation to diseases and disorders such as; chronic heart failure, cancer, diabetes, stroke, chronic obstructive pulmonary disease (COPD) and many more\u003c\/li\u003e \u003cli\u003eDiscusses the role the different tools offered in imaging for PE, including echocardiography, multidetector computed tomography (CT), single photon emission computed tomography (SPECT), ventilation-perfusion (V-Q) imaging, dual energy CT, and magnetic resonance angiography\u003c\/li\u003e \u003cli\u003eContains 29 new chapters and includes new content on epidemiology of deep venous thrombosis; use of the new anticoagulants (dabigatran, rivaroxaban, and apixaban) for DVT and PE; indications and results with thrombolytic therapy and with vena cava filters; and information and indications for invasive mechanical thrombectomy and thrombolysis\u003c\/li\u003e \u003cli\u003eWritten by an internationally recognized and respected expert in the field\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003ePrologue xi\u003c\/p\u003e \u003cp\u003ePreface to the Third Edition xiii\u003c\/p\u003e \u003cp\u003eAbout the companion website xv\u003c\/p\u003e \u003cp\u003eIntroduction 1\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I Prevalence, risks, and prognosis of pulmonary embolism and deep venous thrombosis\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Pulmonary embolism and deep venous thrombosis at autopsy 5\u003c\/p\u003e \u003cp\u003e2 Incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients and in emergency departments 18\u003c\/p\u003e \u003cp\u003e3 Case fatality rate and population mortality rate from pulmonary embolism and deep venous thrombosis 24\u003c\/p\u003e \u003cp\u003e4 Prognosis in acute pulmonary embolism based on right ventricular enlargement and biochemical markers in stable patients 31\u003c\/p\u003e \u003cp\u003e5 Prognosis in acute pulmonary embolism based on scoring systems 43\u003c\/p\u003e \u003cp\u003e6 Pulmonary embolism following deep venous thrombosis and outcome with untreated pulmonary embolism 49\u003c\/p\u003e \u003cp\u003e7 Resolution of pulmonary embolism 54\u003c\/p\u003e \u003cp\u003e8 Upper extremity deep venous thrombosis 61\u003c\/p\u003e \u003cp\u003e9 Thromboembolic disease involving the superior vena cava and brachiocephalic veins 66\u003c\/p\u003e \u003cp\u003e10 Venous thromboembolic disease in the four seasons 69\u003c\/p\u003e \u003cp\u003e11 Regional differences in the United States of rates of diagnosis of pulmonary embolism and deep venous thrombosis and mortality from pulmonary embolism 73\u003c\/p\u003e \u003cp\u003e12 Venous thromboembolism according to age and in the elderly 78\u003c\/p\u003e \u003cp\u003e13 Pulmonary thromboembolism in infants and children 95\u003c\/p\u003e \u003cp\u003e14 Venous thromboembolism in men and women 99\u003c\/p\u003e \u003cp\u003e15 Pulmonary embolism and deep venous thrombosis in blacks and whites 103\u003c\/p\u003e \u003cp\u003e16 Pulmonary thromboembolism in Asians\/Pacific Islanders 108\u003c\/p\u003e \u003cp\u003e17 Pulmonary thromboembolism in American Indians and Alaskan Natives 116\u003c\/p\u003e \u003cp\u003e18 Venous thromboembolism in patients with cancer 118\u003c\/p\u003e \u003cp\u003e19 Venous thromboembolism in patients with heart failure 128\u003c\/p\u003e \u003cp\u003e20 Obesity as a risk factor in venous thromboembolism 133\u003c\/p\u003e \u003cp\u003e21 Hypertension, smoking, and cholesterol 139\u003c\/p\u003e \u003cp\u003e22 Overlap of venous and arterial thrombosis risk factors 141\u003c\/p\u003e \u003cp\u003e23 Venous thromboembolism in patients with ischemic and hemorrhagic stroke 143\u003c\/p\u003e \u003cp\u003e24 Paradoxical embolism 146\u003c\/p\u003e \u003cp\u003e25 Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease 149\u003c\/p\u003e \u003cp\u003e26 Pulmonary embolism and deep venous thrombosis in hospitalized patients with asthma 156\u003c\/p\u003e \u003cp\u003e27 Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease 158\u003c\/p\u003e \u003cp\u003e28 Diabetes mellitus and risk of venous thromboembolism 162\u003c\/p\u003e \u003cp\u003e29 Risk of venous thromboembolism with rheumatoid arthritis 164\u003c\/p\u003e \u003cp\u003e30 Venous thromboembolism with inflammatory bowel disease 166\u003c\/p\u003e \u003cp\u003e31 Venous thromboembolism with chronic liver disease 168\u003c\/p\u003e \u003cp\u003e32 Nephrotic syndrome 171\u003c\/p\u003e \u003cp\u003e33 Human immunodeficiency virus infection 173\u003c\/p\u003e \u003cp\u003e34 Venous thromboembolism in pregnancy 176\u003c\/p\u003e \u003cp\u003e35 Amniotic fluid embolism 182\u003c\/p\u003e \u003cp\u003e36 Air travel as a risk for pulmonary embolism and deep venous thrombosis 184\u003c\/p\u003e \u003cp\u003e37 Estrogen-containing oral contraceptives and venous thromboembolism 187\u003c\/p\u003e \u003cp\u003e38 Estrogen and testosterone in men 192\u003c\/p\u003e \u003cp\u003e39 Tamoxifen 194\u003c\/p\u003e \u003cp\u003e40 Venous thromboembolism following bariatric surgery 198\u003c\/p\u003e \u003cp\u003e41 Hypercoagulable syndrome 204\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II Diagnosis of deep venous thrombosis\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e42 Deep venous thrombosis of the lower extremities: clinical evaluation 215\u003c\/p\u003e \u003cp\u003e43 Clinical scoring system for assessment of deep venous thrombosis 220\u003c\/p\u003e \u003cp\u003e44 Clinical probability score plus single negative ultrasound for exclusion of deep venous thrombosis 223\u003c\/p\u003e \u003cp\u003e45 D-dimer for the exclusion of acute deep venous thrombosis 225\u003c\/p\u003e \u003cp\u003e46 D-dimer combined with clinical probability assessment for exclusion of acute deep venous thrombosis 234\u003c\/p\u003e \u003cp\u003e47 D-dimer and single negative compression ultrasound for exclusion of deep venous thrombosis 236\u003c\/p\u003e \u003cp\u003e48 Contrast venography 237\u003c\/p\u003e \u003cp\u003e49 Compression ultrasound for the diagnosis of deep venous thrombosis 240\u003c\/p\u003e \u003cp\u003e50 Impedance plethysmography and fibrinogen uptake tests for diagnosis of deep venous thrombosis 247\u003c\/p\u003e \u003cp\u003e51 Ascending CT venography and venous phase CT venography for diagnosis of deep venous thrombosis 250\u003c\/p\u003e \u003cp\u003e52 Magnetic resonance venography for diagnosis of deep venous thrombosis 255\u003c\/p\u003e \u003cp\u003e53 P-selectin and microparticles to predict deep venous thrombosis 260\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III Diagnosis of acute pulmonary embolism\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e54 Clinical characteristics of patients with no prior cardiopulmonary disease 265\u003c\/p\u003e \u003cp\u003e55 Relation of right-sided pressures to clinical characteristics of patients with no prior cardiopulmonary disease 272\u003c\/p\u003e \u003cp\u003e56 The history and physical examination in all patients irrespective of prior cardiopulmonary disease 275\u003c\/p\u003e \u003cp\u003e57 Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes 280\u003c\/p\u003e \u003cp\u003e58 Clinical assessment in the critically ill 286\u003c\/p\u003e \u003cp\u003e59 The electrocardiogram 289\u003c\/p\u003e \u003cp\u003e60 The plain chest radiograph 303\u003c\/p\u003e \u003cp\u003e61 Arterial blood gases and the alveolar–arterial oxygen difference in acute pulmonary embolism 308\u003c\/p\u003e \u003cp\u003e62 Fever in acute pulmonary embolism 316\u003c\/p\u003e \u003cp\u003e63 Leukocytosis in acute pulmonary embolism 319\u003c\/p\u003e \u003cp\u003e64 Alveolar dead-space in the diagnosis of pulmonary embolism 321\u003c\/p\u003e \u003cp\u003e65 Empirical assessment and clinical models for diagnosis of acute pulmonary embolism 324\u003c\/p\u003e \u003cp\u003e66 Prognostic models for pulmonary embolism 329\u003c\/p\u003e \u003cp\u003e67 D-dimer for the exclusion of acute pulmonary embolism 335\u003c\/p\u003e \u003cp\u003e68 D-dimer combined with clinical probability for exclusion of acute pulmonary embolism 346\u003c\/p\u003e \u003cp\u003e69 D-dimer in combination with amino-terminal pro-B-type natriuretic peptide for exclusion of acute pulmonary embolism 349\u003c\/p\u003e \u003cp\u003e70 Tissue plasminogen activator, plasminogen activator inhibitor-1, and thrombin – antithrombin III complexes in the exclusion of acute pulmonary embolism 350\u003c\/p\u003e \u003cp\u003e71 Echocardiogram in the diagnosis of acute pulmonary embolism 352\u003c\/p\u003e \u003cp\u003e72 Trends in the use of diagnostic imaging in patients hospitalized with acute pulmonary embolism 356\u003c\/p\u003e \u003cp\u003e73 Techniques of perfusion and ventilation imaging 358\u003c\/p\u003e \u003cp\u003e74 Ventilation – perfusion lung scan criteria for interpretation prior to the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) 363\u003c\/p\u003e \u003cp\u003e75 Observations from PIOPED: ventilation – perfusion lung scans alone and in combination with clinical assessment 367\u003c\/p\u003e \u003cp\u003e76 Ventilation – perfusion lung scans according to complexity of lung disease 374\u003c\/p\u003e \u003cp\u003e77 Perfusion lung scans alone in acute pulmonary embolism 376\u003c\/p\u003e \u003cp\u003e78 Probability interpretation of ventilation – perfusion lung scans in relation to the largest pulmonary arterial branches in which pulmonary embolism is observed 379\u003c\/p\u003e \u003cp\u003e79 Revised criteria for evaluation of lung scans recommended by nuclear physicians in PIOPED 381\u003c\/p\u003e \u003cp\u003e80 Criteria for very-low-probability interpretation of ventilation – perfusion lung scans 385\u003c\/p\u003e \u003cp\u003e81 Probability assessment based on the number of mismatched segmental equivalent perfusion defects 391\u003c\/p\u003e \u003cp\u003e82 Probability assessment based on the number of mismatched vascular defects and stratification according to prior cardiopulmonary disease 395\u003c\/p\u003e \u003cp\u003e83 The addition of clinical assessment to stratification according to prior cardiopulmonary disease further optimizes the interpretation of ventilation – perfusion lung scans 401\u003c\/p\u003e \u003cp\u003e84 Pulmonary scintigraphy scans since PIOPED 407\u003c\/p\u003e \u003cp\u003e85 Single photon emission computed tomographic (SPECT) lung scans 412\u003c\/p\u003e \u003cp\u003e86 SPECT with radiolabeled markers 426\u003c\/p\u003e \u003cp\u003e87 Standard and augmented techniques in pulmonary angiography 427\u003c\/p\u003e \u003cp\u003e88 Subsegmental pulmonary embolism 435\u003c\/p\u003e \u003cp\u003e89 Quantification of pulmonary embolism by conventional and CT angiography 440\u003c\/p\u003e \u003cp\u003e90 Complications of pulmonary angiography 442\u003c\/p\u003e \u003cp\u003e91 Contrast-enhanced spiral CT for the diagnosis of acute pulmonary embolism before the Prospective Investigation of Pulmonary Embolism Diagnosis II 446\u003c\/p\u003e \u003cp\u003e92 Methods of PIOPED II 458\u003c\/p\u003e \u003cp\u003e93 Multidetector spiral CT of the chest for acute pulmonary embolism: results of the PIOPED II trial 467\u003c\/p\u003e \u003cp\u003e94 Multidetector CT pulmonary angiography since PIOPED II 473\u003c\/p\u003e \u003cp\u003e95 Outcome studies of pulmonary embolism versus accuracy 478\u003c\/p\u003e \u003cp\u003e96 Contrast-induced nephropathy 480\u003c\/p\u003e \u003cp\u003e97 Radiation exposure and risk 483\u003c\/p\u003e \u003cp\u003e98 Magnetic resonance angiography for the diagnosis of acute pulmonary embolism 490\u003c\/p\u003e \u003cp\u003e99 Serial noninvasive leg tests in patients with suspected pulmonary embolism 499\u003c\/p\u003e \u003cp\u003e100 Diagnosis of pulmonary embolism in the coronary care unit 501\u003c\/p\u003e \u003cp\u003e101 Silent pulmonary embolism with deep venous thrombosis 506\u003c\/p\u003e \u003cp\u003e102 Fat embolism syndrome 511\u003c\/p\u003e \u003cp\u003e103 Diagnostic approach to acute pulmonary embolism 516\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV Prevention and treatment of deep venous thrombosis and pulmonary embolism\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e104 Warfarin and other vitamin K antagonists 523\u003c\/p\u003e \u003cp\u003e105 Unfractionated heparin, low-molecular-weight heparin, heparinoid, and pentasaccharide 531\u003c\/p\u003e \u003cp\u003e106 Parenteral inhibitors of factors Va, VIIIa, tissue factor, and thrombin 540\u003c\/p\u003e \u003cp\u003e107 Novel oral anticoagulants 545\u003c\/p\u003e \u003cp\u003e108 Aspirin for venous thromboembolism 552\u003c\/p\u003e \u003cp\u003e109 Immediate therapeutic levels of heparin in relation to timing of recurrent events 555\u003c\/p\u003e \u003cp\u003e110 Intermittent pneumatic compression 558\u003c\/p\u003e \u003cp\u003e111 Graduated compression stockings 561\u003c\/p\u003e \u003cp\u003e112 Ankle exercise and venous blood velocity 565\u003c\/p\u003e \u003cp\u003e113 Thrombolytic therapy for deep venous thrombosis 567\u003c\/p\u003e \u003cp\u003e114 Mechanical and ultrasonic enhancement of catheter-directed thrombolytic therapy for deep venous thrombosis 572\u003c\/p\u003e \u003cp\u003e115 Thrombolytic therapy for treatment of acute pulmonary embolism 574\u003c\/p\u003e \u003cp\u003e116 Catheter-tip embolectomy in the management of acute massive pulmonary embolism 589\u003c\/p\u003e \u003cp\u003e117 Vena cava filters 597\u003c\/p\u003e \u003cp\u003e118 Withholding treatment of patients with acute pulmonary embolism who have a high risk of bleeding provided and negative serial noninvasive leg tests 615\u003c\/p\u003e \u003cp\u003e119 Home treatment of deep venous thrombosis 617\u003c\/p\u003e \u003cp\u003e120 Home treatment of acute pulmonary embolism 622\u003c\/p\u003e \u003cp\u003e121 Pulmonary embolectomy 626\u003c\/p\u003e \u003cp\u003e122 Chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy 634\u003c\/p\u003e \u003cp\u003e123 Prevention and treatment of deep venous thrombosis and acute pulmonary embolism: American College of Chest Physicians Guidelines 639\u003c\/p\u003e \u003cp\u003eIndex 647\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePaul D. Stein MD\u003c\/b\u003e,Professor of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA.\u003c\/p\u003e \u003cp\u003eDr. Stein's major research in recent years has been in the field of venous thromboembolism. Dr. Stein initiated the PIOPED II and PIOPED III national collaborative studies and was national principal investigator and chairperson of the steering committees. He has written over 240 articles on venous thromboembolism from among over 560 peer reviewed articles. Dr Stein is a past president of the Laennec Society and of the American College of Chest Physicians. He is Fellow of the American College of Physicians and the American College of Cardiology and a Master Fellow of the American College of Chest Physicians. He is also a Fellow of the American Society of Mechanical Engineers. Fellowship is reserved for those who have made a significant contribution to the field of mechanical engineering. He received the Lifetime Achievement Award from the American Heart Association Midwest Affiliate, the Laureate Award of the American College of Physicians, Michigan Chapter, the Daniel Drake Award from the University of Cincinnati College of Medicine, and the Research Excellence Award from the Michigan State University College of Osteopathic Medicine.  Dr. Stein also wrote a book, \u003ci\u003eA Physical and Physiological Basis for the Interpretation of Cardiac Auscultation:  Evaluations Based Primarily on Second Sound and Ejection Murmurs\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003ePulmonary embolism (PE) is the third most common acute cardiovascular disease after acute myocardial infarction and stroke. This fully updated third edition supplies the latest information on epidemiology, methods of diagnosis, preferred diagnostic pathways, new medications including the new anticoagulants, and new recommendations for prophylaxis and treatment of pulmonary embolism and its immediate cause, deep vein thrombosis.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eAn essential and comprehensive resource for physicians and allied professionals in the field of this difficult-to-diagnose and life threatening condition\u003c\/li\u003e \u003cli\u003eHighly illustrated with numerous tables and graphs alongside clear concise text\u003c\/li\u003e \u003cli\u003eIncludes chapters addressing pulmonary embolism (PE) and deep venous thrombosis (DVT) in relation to diseases and disorders such as; chronic heart failure, cancer, diabetes, stroke, chronic obstructive pulmonary disease (COPD) and many more\u003c\/li\u003e \u003cli\u003eDiscusses the role the different tools in imaging for PE, including, echocardiography, multidetector computed tomography (CT), single photon emission computed tomography (SPECT), ventilation-perfusion (V-Q) imaging, dual energy CT, and magnetic resonance angiography\u003c\/li\u003e \u003cli\u003eContains 29 new chapters and includes new content on epidemiology of deep venous thrombosis; use of the new anticoagulants (dabigatran, rivaroxaban, and apixaban) for DVT and PE; indications and results with thrombolytic therapy and with vena cava filters; and information and indications for invasive mechanical thrombectomy\u003c\/li\u003e \u003cli\u003eWritten by an internationally recognized and respected expert in the field\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThis book is a dependable and well referenced resource for in-depth information about pulmonary embolism (PE) and deep venous thrombosis (DVT).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePraise for previous editions\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"I would recommend this book to all physicians looking after patients with venous thromboembolism … .The single author style has the advantage of a consistent format and lack of repetition, and the book is very well written.\" (\u003ci\u003eCardiology News\u003c\/i\u003e, December 2008)\u003c\/p\u003e \u003cp\u003e\"Paul Stein … has used his vast knowledge and perspective to organize [t]his definitive text … .In this long-awaited second edition he builds on the knowledge base regarding this common and yet often misdiagnosed condition. This text fills a gap in the knowledge-base of the physician, nurse, or therapist who cares for patients with pulmonary embolism. By using a clear and organized format with many graphs and diagrams, Stein provides detailed information beyond the scope of an online review, but in a readily searchable and easily accessible format. Stein does a nice job of explaining the challenges of using intermediate end points in the assessment of efficacy. Stein is clearly one of the world’s experts, and this far-reaching volume is a pleasure to read.\" (\u003ci\u003eRespiratory Care\u003c\/i\u003e, September 2008)\u003c\/p\u003e \u003cp\u003e\"This textbook is cohesive, tightly organized, and has no repetition…. It is beautifully illustrated…[and] is my 'go to' source for rapid reference.\" (\u003ci\u003eJournal of Interventional Cardiology\u003c\/i\u003e)\u003c\/p\u003e \u003cp\u003e\"An excellent contribution to the relevant contemporary literature…. I enjoyed reading the book and recommend it to my colleagues.\" (\u003ci\u003eWorld Journal of Surgery\u003c\/i\u003e)\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989889761509,"sku":"NP9781119039082","price":184.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119039082.jpg?v=1761785807","url":"https:\/\/k12savings.com\/products\/pulmonary-embolism-isbn-9781119039082","provider":"K12savings","version":"1.0","type":"link"}